Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deal Watch: Gilead’s Immunology Collaboration With Verily Continues Pivot Away From Virology

Executive Summary

Gilead’s tie-up with Google’s Verily will explore the immunological underpinnings of rheumatoid arthritis, lupus and GI disorders. Janssen acquires BeneVir and its oncolytic virus expertise, while United Therapeutics buys out SteadyMed.
Advertisement

Related Content

Yescarta One Of Few Gilead Bright Spots, And Now It Has A Competing CAR-T
Q1 Was Slow For Deals, But That Could Change With One Big Transaction – PwC
'Watch This Space' Roche Execs Say, Outlining RWE Rationale For Flatiron Buy
Deal Watch Asia Focus: Pfenex Licenses Asian Rights To Forteo Copy To NT Pharma Group
Orexigen Follows Through On Warning It May Have To Liquidate
Novartis Teams With Pear Therapeutics In Neurological Digital Health Pact
Biogen Spooks With Phase III Aducanumab Changes
Opioid Use Disorder App Marks A Path For 510(k) 'Breakthrough' Devices
First Anti-Addiction App Approved In The US
Deal Watch: United Therapeutics Looks To Extend PAH Dominance With Respira's Combo Product

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC123020

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel